Douglas J. Seith serves as the Chief Operating Officer at AtriCure, Inc., a medical device company focused on developing and commercializing innovative solutions for the treatment of atrial fibrillation and related conditions. With a strong background in the medical device industry, Seith has been instrumental in driving the company's operational success and strategic growth. In his role as COO, he oversees the company's global operations, including manufacturing, supply chain, and quality assurance, ensuring that AtriCure continues to deliver high-quality products to its customers worldwide. Prior to joining AtriCure, Seith held various leadership positions at leading medical device companies, where he gained extensive experience in operations, product development, and business strategy. His career highlights include successfully leading cross-functional teams to bring new products to market, implementing lean manufacturing processes to improve efficiency, and driving organizational growth through strategic initiatives. Seith's strong leadership skills and deep understanding of the medical device industry have been key factors in his ability to effectively manage AtriCure's operations and contribute to the company's overall success. As COO of AtriCure, Seith plays a critical role in the company's mission to improve the lives of patients suffering from atrial fibrillation and other cardiac conditions. He works closely with the executive team to develop and execute the company's strategic plan, focusing on expanding the company's product portfolio, enhancing its global presence, and driving operational excellence. Under his leadership, AtriCure has continued to innovate and grow, solidifying its position as a leader in the field of cardiac ablation technologies.